NDUFA12 and liver cancer: These results indicated that NDUFA12 expression was approximately three times higher in the HepG2 liver cancer cell line compared to the normal liver cell line HL-7702 (Supplementary Figure S3), suggesting that NDUFA12 is overexpressed in liver cancer cells and may be a promising biological target for liver cancer treatment.